TABLE 1. Antithrombotic agents and its reversal agents.
Drug | Reversal agent | Dose | |
---|---|---|---|
Antiplatelet drugs | Aspirin, clopidogrel, cilostizol | Platelet | >3×109 platelet/L 1 U |
Parenteral anticoagulants | Heparin | Protamine | 1 mg IV per 100 U of heparin over last 4 hours (maximum 50 mg) |
Enoxaparin | Protamine | 1 mg IV per 1 mg of LMWH (maximum 50 mg) | |
Oral anticoagulants | Warfarin | Vitamin K | 1–2 mg IV or PO 2.5–10 mg q 12 hours |
FFP | Administer until corrected | ||
PCC | 25 U/kg IV for INR 2–4, 35 U/kg IV for INR 4–6, 50 U/kg IV for INR >6 | ||
Rivaroxaban | PCC | 50 IU/kg IV | |
Andexanet alfa | 400–800 mg IV bolus, 480–960 mg infusion | ||
Apixaban | PCC | 50 IU/kg IV | |
Andexanet alfa | 400 mg IV bolus, 480 mg infusion | ||
Edoxaban | PCC | 50 IU/kg IV | |
Andexanet alfa | 800 mg IV bolus, 960 mg infusion | ||
Dabigatran | Idarucizumab | 5g IV bolus |
FFP: fresh-frozen plasma, PCC: prothrombin complex concentrate, INR: international normalized rat.